A global comparative study on MDT practices in the management of hepatocellular carcinoma in high-income countries (HICs) and low- and middle-income countries (LMICs).

被引：0

作者：

Jonas, Eduard

Liu, Lianxin ^{[1
]}

Smith, Martin ^{[2
]}

Soliman, Hossam El-Deen Mohamed ^{[3
]}

Li, Jiaping ^{[4
]}

Wang, Jizhou

Fan, Wenzhe

Zeid, Ahmed Elsayed Esmaal ^{[5
]}

Devar, John

Zhang, Erlei

Chen, Qian

Yin, Bichai ^{[6
]}

Cui, Poka Yingjing

Dong, Yufang ^{[7
]}

Su, Zoe

Azcue, Pablo ^{[8
]}

Turner, Lucy ^{[9
]}

Partera, Maria Teresa Campos ^{[10
]}

Chen, Xiaoping

机构：

[1] First Affiliated Hosp USTC, Hefei, Peoples R China

[2] Univ Witwatersrand, Johannesburg, South Africa

[3] Menoufia Univ, Natl Liver Inst, Shibin Al Kawm, Egypt

[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China

[5] Alexandria Univ, Fac Med, Alexandria, Egypt

[6] Vintura, Baarn, Netherlands

[7] AstraZeneca, Shanghai, Peoples R China

[8] AstraZeneca, Zug, Switzerland

[9] AstraZeneca Plc, Cambridge, England

[10] AstraZeneca, Barcelona, Spain

来源：

关键词：

D O I：

10.1200/JCO.2025.43.4_suppl.562

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1